Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascentage, Beyondspring, Bionomics, Bioxcel, CTI, Cytodyn, Harmony, Huyabio, Innovent, Merck, Moleculin, Ridgeback, Shenzhen Chipscreen, Secura, Siga, Statera, Surface, Telix, VBI, Zogenix.